| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92ebee933d7b49d9a67bd55f31ce03c0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-02 |
| filingDate |
2020-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed9425bfc1c73ae6b33732b94d57c4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b276cd5be6e5215276ca73cc137af70 |
| publicationDate |
2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020172615-A1 |
| titleOfInvention |
Compounds for the treatment of ocular disease |
| abstract |
Disclosed herein are compounds for the treatment of ocular diseases and the preparation and use thereof. Some implementations relate to amine and sulfonamide derivatives and their use as therapeutic agents for the treatment of glaucoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11019996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11019997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078161-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023094828-A1 |
| priorityDate |
2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |